Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (N-Term) Peptide
LRRFIP1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all LRRFIP1 products
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-LRRFIP1 antibody (Catalog #: ARP38506_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
- Background
-
LRRFIP1 is a transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. LRRFIP1 may control smooth muscle cells proliferation following artery injury throu
Alias Symbols: FLAP-1, FLIIAP1, GCF-2, GCF2, HUFI-1, MGC10947, MGC119738, MGC119739, TRIP, FLAP1
Protein Interaction Partner: FLII,FLII
Protein Size: 784 - Molecular Weight
- 86 kDa
- Gene ID
- 9208
- NCBI Accession
- NM_004735, NP_004726
-
You are here:
